Follow-up practice and healthcare utilisation of colorectal cancer survivors

Seyed M. Qaderi*, Nicole P. M. Ezendam, Rob H. A. Verhoeven, Jose A. E. Custers, Johannes H. W. de Wilt, Floortje Mols

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Objective: To examine healthcare utilisation and adherence to colorectal cancer (CRC) follow-up guidelines. Methods: A total of 2450 out of 3025 stage I-III CRC survivors diagnosed between 2000 and 2009 completed the Hospital Anxiety and Depression Scale, SF-12, EORTC QLQ-CR38 and Fatigue Assessment Score questionnaires, in December 2010. Multivariable regression analyses were performed to identify predictors for increased follow-up care (>1 visit than recommended by guidelines). Results: In the first follow-up year, the average number of cancer-related visits to the general practitioner and medical specialist was 1.7 and 4.2, respectively. More than 80% of the CRC survivors was comfortable with their follow-up schedule, and 49–72% of them received follow-up according to the guidelines. Around 29–47% was followed more than recommended. Simultaneously, around 4–14% of the CRC survivors received less follow-up care than recommended. Survivors of stage III disease treated with chemotherapy received the most follow-up care. In addition, lower socio-economic status stoma and fatigue were associated with increased follow-up care. Conclusion: CRC survivors were predominantly followed according to national guidelines. Increased follow-up care is driven by advanced disease stage, chemotherapy, SES, stoma and fatigue. Future studies should investigate how increased follow-up care use can be reduced, while still addressing patients’ needs.
Original languageEnglish
Article numbere13472
JournalEuropean Journal of Cancer Care
Issue number5
Early online date2021
Publication statusPublished - Sep 2021

Cite this